R & D Pipeline

Differentiated Pipeline to Support “Best-in Disease Combination with Global Impact

Partnering with us

  • Categories:Partnerships
  • Time of issue:2019-07-31 00:00:00
  • Views:0

Partnering with the best early stage science and clinical-stage programs is our top priority. We are dedicated to building strong partnership with top-tier research institutes, biotech and pharmaceutical companies. Our initial focus is to partner with assets with potential synergy with our current portfolio to enable us to select the winning combination and deliver meaningful benefit in the fight against cancer.

BD related business please contact Email:BD@inxmed.com


Scan the QR code to read on your phone


Copyright © 2019  InxMed  京ICP备19001572号-1  Powered by 300.cn